首页 > 最新文献

TP132. TP132 EPIDEMIOLOGY AND GENETICS OF SLEEP DISORDERS: EXAMINE THE LATEST ADVANCES!最新文献

英文 中文
Divergent Responses of Human Melanoma Cells to Chronic Intermittent Hypoxia in an In Vitro Model of Sleep Apnea 体外睡眠呼吸暂停模型中人类黑色素瘤细胞对慢性间歇性缺氧的不同反应
Pub Date : 1900-01-01 DOI: 10.1164/ajrccm-conference.2021.203.1_meetingabstracts.a4725
A.L. Castro, Q. Zhuanghong, A. Khalyfa, L. Gozal, D. Gozal
{"title":"Divergent Responses of Human Melanoma Cells to Chronic Intermittent Hypoxia in an In Vitro Model of Sleep Apnea","authors":"A.L. Castro, Q. Zhuanghong, A. Khalyfa, L. Gozal, D. Gozal","doi":"10.1164/ajrccm-conference.2021.203.1_meetingabstracts.a4725","DOIUrl":"https://doi.org/10.1164/ajrccm-conference.2021.203.1_meetingabstracts.a4725","url":null,"abstract":"","PeriodicalId":277679,"journal":{"name":"TP132. TP132 EPIDEMIOLOGY AND GENETICS OF SLEEP DISORDERS: EXAMINE THE LATEST ADVANCES!","volume":"153 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"1900-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"123287808","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Sleep Apnea Diagnosed by Full Polysomnography Is a Factor of Acute Hypoxic Respiratory Failure in Covid-19: A Prospective Clinical-Based Cohort Study 全多导睡眠图诊断的睡眠呼吸暂停是Covid-19急性缺氧呼吸衰竭的一个因素:一项前瞻性临床队列研究
Pub Date : 1900-01-01 DOI: 10.1164/ajrccm-conference.2021.203.1_meetingabstracts.a4724
R. Tamisier, L. Boyer, C. Planès, B. Chenuel, S. Bailly, G. Derumeaux, T. d'Humières, T. Gille, L. Sese, N. Terzi, J. Pepin
Introduction: COVID-19 is a respiratory disease with clinical manifestation, severity, and outcomes heterogeneity, from asymptomatic presentation to an acute hypoxemic respiratory failure. Clinical characteristics and comorbidities may affect susceptibility to a more severe COVID-19. We hypothesize that obstructive sleep apnea (OSA) may be a significant factor that mitigates COVID-19 severity. Methods: A prospective multicentric cohort "Co-survivors" with a sample size of 400 patients was set and started recruiting in June 2020. Patients with a respiratory presentation of COVID-19 were selected. All severities of COVID-19 were allowed from outpatients to patients requiring prolonged invasive mechanical ventilation. At 3-months follow-up, patients underwent a cardio-respiratory clinical investigation. Initial and actual clinical manifestations and comorbidities were collected. All patients underwent a full polysomnography (PSG) or respiratory polygraphy (PG). Results: At the time of the analysis, 121 patients were included in the cohort. OSA was diagnosed before COVID-19 and already treated in 10 patients, and 23 were waiting for investigation. Full PSG was performed in 88 patients (80 PSG and 8 PG). OSA was absent in 15 (17%) patients, while mild, moderate, and severe OSA was present in 30 (34.1%), 21 (23.9%) and 22 (25%), respectively. Outpatient COVID-19 was reported in 30 (34.1%), hospitalization was needed without and with acute respiratory failure in 13 (14%) and 45 (51%) patients, respectivelly. These later were predominantly male and older, did not exhibit more comorbidity but metabolic characteristics with significant higher body mass index and waist circumference. Sleep recordings revealed an AHI of 7.4 [1.7;15.4], 15.7 [8.3;48.9] and 21.9 [14;35.1] p<0.01 in these three classes of COVID-19 severity, respectively. Finally, undiagnosed OSA was a factor of COVID-19 severity. Conclusions: Patients with OSA are highly represented in a population of COVID-19 survivors. About 10% of the patients were diagnosed prior to infection, undiagnosed moderate or severe OSA was diagnosed in 48.9% of the remaining patents. Moreover, OSA is likely to be a factor of acute respiratory failure in patients infected with SARS-CoV-2.
COVID-19是一种具有临床表现、严重程度和结局异质性的呼吸系统疾病,可从无症状表现到急性低氧性呼吸衰竭。临床特征和合并症可能影响对更严重的COVID-19的易感性。我们假设阻塞性睡眠呼吸暂停(OSA)可能是减轻COVID-19严重程度的一个重要因素。方法:建立了一个前瞻性多中心队列“共同幸存者”,样本量为400例,并于2020年6月开始招募。选择有COVID-19呼吸道症状的患者。所有严重程度的COVID-19都允许从门诊患者到需要长时间有创机械通气的患者。在3个月的随访中,患者进行了心肺临床调查。收集患者的初始和实际临床表现及合并症。所有患者均进行了完整的多导睡眠图(PSG)或呼吸多导睡眠图(PG)检查。结果:在分析时,121例患者被纳入队列。OSA是在新冠肺炎之前被诊断出来的,已经有10名患者接受了治疗,23名患者正在等待调查。88例患者行全PSG(80例PSG, 8例PG)。15例(17%)患者无OSA,轻度、中度和重度OSA分别为30例(34.1%)、21例(23.9%)和22例(25%)。门诊报告新冠肺炎患者30例(34.1%),无急性呼吸衰竭住院13例(14%),伴有急性呼吸衰竭住院45例(51%)。这些晚期患者主要是男性和老年人,没有表现出更多的合并症,但代谢特征明显较高的体重指数和腰围。睡眠记录显示,这三类COVID-19严重程度的AHI分别为7.4[1.7;15.4]、15.7[8.3;48.9]和21.9[14;35.1]和0.01。最后,未确诊的OSA是COVID-19严重程度的一个因素。结论:OSA患者在COVID-19幸存者人群中具有很高的代表性。约10%的患者在感染前被诊断,48.9%的患者被诊断为未确诊的中重度OSA。此外,OSA可能是SARS-CoV-2感染患者急性呼吸衰竭的一个因素。
{"title":"Sleep Apnea Diagnosed by Full Polysomnography Is a Factor of Acute Hypoxic Respiratory Failure in Covid-19: A Prospective Clinical-Based Cohort Study","authors":"R. Tamisier, L. Boyer, C. Planès, B. Chenuel, S. Bailly, G. Derumeaux, T. d'Humières, T. Gille, L. Sese, N. Terzi, J. Pepin","doi":"10.1164/ajrccm-conference.2021.203.1_meetingabstracts.a4724","DOIUrl":"https://doi.org/10.1164/ajrccm-conference.2021.203.1_meetingabstracts.a4724","url":null,"abstract":"Introduction: COVID-19 is a respiratory disease with clinical manifestation, severity, and outcomes heterogeneity, from asymptomatic presentation to an acute hypoxemic respiratory failure. Clinical characteristics and comorbidities may affect susceptibility to a more severe COVID-19. We hypothesize that obstructive sleep apnea (OSA) may be a significant factor that mitigates COVID-19 severity. Methods: A prospective multicentric cohort \"Co-survivors\" with a sample size of 400 patients was set and started recruiting in June 2020. Patients with a respiratory presentation of COVID-19 were selected. All severities of COVID-19 were allowed from outpatients to patients requiring prolonged invasive mechanical ventilation. At 3-months follow-up, patients underwent a cardio-respiratory clinical investigation. Initial and actual clinical manifestations and comorbidities were collected. All patients underwent a full polysomnography (PSG) or respiratory polygraphy (PG). Results: At the time of the analysis, 121 patients were included in the cohort. OSA was diagnosed before COVID-19 and already treated in 10 patients, and 23 were waiting for investigation. Full PSG was performed in 88 patients (80 PSG and 8 PG). OSA was absent in 15 (17%) patients, while mild, moderate, and severe OSA was present in 30 (34.1%), 21 (23.9%) and 22 (25%), respectively. Outpatient COVID-19 was reported in 30 (34.1%), hospitalization was needed without and with acute respiratory failure in 13 (14%) and 45 (51%) patients, respectivelly. These later were predominantly male and older, did not exhibit more comorbidity but metabolic characteristics with significant higher body mass index and waist circumference. Sleep recordings revealed an AHI of 7.4 [1.7;15.4], 15.7 [8.3;48.9] and 21.9 [14;35.1] p<0.01 in these three classes of COVID-19 severity, respectively. Finally, undiagnosed OSA was a factor of COVID-19 severity. Conclusions: Patients with OSA are highly represented in a population of COVID-19 survivors. About 10% of the patients were diagnosed prior to infection, undiagnosed moderate or severe OSA was diagnosed in 48.9% of the remaining patents. Moreover, OSA is likely to be a factor of acute respiratory failure in patients infected with SARS-CoV-2.","PeriodicalId":277679,"journal":{"name":"TP132. TP132 EPIDEMIOLOGY AND GENETICS OF SLEEP DISORDERS: EXAMINE THE LATEST ADVANCES!","volume":"1 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"1900-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"123589358","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Sleep Duration Is Positively Correlated with Plasma IL-10 in African American and White Participants with a Parental History of Alzheimer’s Disease 在父母有阿尔茨海默病史的非裔美国人和白人参与者中,睡眠时间与血浆IL-10呈正相关
Pub Date : 1900-01-01 DOI: 10.1164/ajrccm-conference.2021.203.1_meetingabstracts.a4717
V. Pak, S. Paul, W. Wharton
{"title":"Sleep Duration Is Positively Correlated with Plasma IL-10 in African American and White Participants with a Parental History of Alzheimer’s Disease","authors":"V. Pak, S. Paul, W. Wharton","doi":"10.1164/ajrccm-conference.2021.203.1_meetingabstracts.a4717","DOIUrl":"https://doi.org/10.1164/ajrccm-conference.2021.203.1_meetingabstracts.a4717","url":null,"abstract":"","PeriodicalId":277679,"journal":{"name":"TP132. TP132 EPIDEMIOLOGY AND GENETICS OF SLEEP DISORDERS: EXAMINE THE LATEST ADVANCES!","volume":"62 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"1900-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"129847791","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The Epidemiology of Nocturnal Hypoxemia on Home Sleep Apnea Testing 夜间低氧血症在家庭睡眠呼吸暂停测试中的流行病学研究
Pub Date : 1900-01-01 DOI: 10.1164/ajrccm-conference.2021.203.1_meetingabstracts.a4720
T. Homan, B. Wichman, M. Uhles, J. Espiritu
{"title":"The Epidemiology of Nocturnal Hypoxemia on Home Sleep Apnea Testing","authors":"T. Homan, B. Wichman, M. Uhles, J. Espiritu","doi":"10.1164/ajrccm-conference.2021.203.1_meetingabstracts.a4720","DOIUrl":"https://doi.org/10.1164/ajrccm-conference.2021.203.1_meetingabstracts.a4720","url":null,"abstract":"","PeriodicalId":277679,"journal":{"name":"TP132. TP132 EPIDEMIOLOGY AND GENETICS OF SLEEP DISORDERS: EXAMINE THE LATEST ADVANCES!","volume":"6 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"1900-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"121852549","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
期刊
TP132. TP132 EPIDEMIOLOGY AND GENETICS OF SLEEP DISORDERS: EXAMINE THE LATEST ADVANCES!
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1